RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 15, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced an update to the timing of its previously announced second quarter earnings conference call. The Company will release its second quarter 2021 results at 6:55 a.m. (EDT) on... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2021 following the close of market on Thursday, August 5, 2021. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 13, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its second quarter 2021 results at 6:55 a.m. (ET) on Tuesday, August 3, 2021. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more
ANDOVER, Mass., July 12, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that the Company will release second quarter 2021 financial results after market close on Wednesday, Read more
Thermo Fisher Scientific To Showcase Investments and Innovation at DCAT Week 2021 Strategic investments over the last two years expand global capabilities to support advanced therapies and large molecule development and manufacturing WALTHAM, Mass., July 12, 2021 /PRNewswire/ — This week, Thermo Fisher Scientific will highlight its investments and innovations over the past 12 months across its... Read more
The authorisation enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalised adult and paediatric patients Basel, 25 June 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19... Read more
06/24/21 MILFORD, Mass.–(BUSINESS WIRE)– Waters Corporation (NYSE: WAT) today announced the appointment of Wei Jiang to its Board of Directors, effective July 14, 2021. Mr. Jiang currently serves as Executive Vice President and President, Bayer Pharmaceuticals Region China & APAC and President, Bayer Group Greater China. Dr. Flemming Ornskov, Chairman of the Board, said, “We... Read more
BOSTON – June 24, 2021– Today GE (NYSE: GE) announced the appointment of Peter Arduini as president and Chief Executive Officer of GE Healthcare effective January 3, 2022. Arduini will succeed Kieran Murphy who will continue to serve in his current role until the end of 2021 and then he will serve as a strategic... Read more
Company anticipates 2Q21 revenue and earnings to be above previously communicated guidance WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 24, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced ahead of this morning’s Virtual Investor and Analyst Day that it anticipates exceeding its previously announced financial guidance for the second quarter... Read more
WASHINGTON, June 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2021 on Thursday, July 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more